Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Drug Discovery: Overview01:26

Drug Discovery: Overview

13.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical Assessment and Tissue Distribution of Vodobatinib, a Third Generation BCr-Abl 1 Inhibitor.

Drug research·2026
Same author

Development and Validation of an LC-MS/MS Method for the Quantitative Estimation of Bexicaserin in Human Cerebrospinal Fluid.

Biomedical chromatography : BMC·2026
Same author

An LC-MS/MS Method for the Quantitation of Metabolites M9, M12, and M20 of Bexicaserin in Human Cerebrospinal Fluid.

Biomedical chromatography : BMC·2026
Same author

Insights Influencing the Selection of Stable Isotopically Labeled Internal Standards (SIL-ISs) for LC-MS/MS Quantitative Assays.

Biomedical chromatography : BMC·2025
Same author

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses and Dose Titration of Bexicaserin in Healthy Participants in a Randomized, Double-Blind, Placebo-Controlled Study.

Clinical pharmacology in drug development·2025
Same author

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Bexicaserin in Healthy Participants: A First-in-Human Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Escalation Phase 1 Study.

Clinical pharmacology in drug development·2025

Related Experiment Video

Updated: Apr 4, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.8K

Bioanalysis in oncology drug discovery.

Nuggehally R Srinivas1, Ramesh Mullangi2

  • 1Dr Reddy's Institute of Life Sciences, Gachibowli, Hyderabad, Telangana, India.

Biomarkers in Medicine
|September 3, 2015
PubMed
Summary

Bioanalysis is crucial in early drug discovery for making informed decisions, such as program termination or differentiating drug candidates. This review highlights its importance in stage gate screens and experimental designs.

Keywords:
LC-MS/MSbioanalysisdrug discoveryoncology

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.7K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.3K

Related Experiment Videos

Last Updated: Apr 4, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.8K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.7K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.3K

Area of Science:

  • Drug Discovery and Development
  • Pharmacokinetics and Pharmacodynamics
  • Biotechnology

Background:

  • Bioanalysis is often underestimated during early drug discovery due to a lack of immediate regulatory scrutiny.
  • A misconception exists that bioanalytical data is less critical in the discovery phase compared to later development stages.
  • Despite this, bioanalytical data plays a pivotal role in guiding critical decisions throughout the drug discovery pipeline.

Purpose of the Study:

  • To underscore the significance of bioanalytical data in the early stages of drug discovery.
  • To illustrate how bioanalytical data informs key decision-making processes, including program continuation or termination.
  • To highlight the utility of bioanalysis in establishing competitive differentiation for drug candidates.

Main Methods:

  • Review of various stage gate screening processes in drug discovery.
  • Analysis of experimental designs where bioanalytical data is integral.
  • Examination of decision-making frameworks informed by bioanalytical findings.

Main Results:

  • Bioanalytical data enables informed decisions regarding program termination.
  • It facilitates the creation of adequate differentiation from competing molecules.
  • The review details specific applications of bioanalytical data in various discovery stages.

Conclusions:

  • Bioanalysis is indispensable throughout the drug discovery process, not just in later regulatory phases.
  • Effective utilization of bioanalytical data optimizes resource allocation and strategic direction in drug development.
  • This review emphasizes the critical role of bioanalysis in successful and efficient drug discovery programs.